Khan, Mosin S <br/><br/>
Epigenetic silencing of TSHR gene in thyroid cancer patients in relation to their BRAF V600E mutation status.  [electronic resource] 

 -  Endocrine  Nov 2014 
 - 449-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-0100 
<br/><br/><label>Standard No.: </label>10.1007/s12020-014-0319-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Follicular--genetics<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Papillary--genetics<br/>DNA Methylation<br/>Epigenesis, Genetic<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Gene Silencing<br/>Humans<br/>MAP Kinase Signaling System--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Promoter Regions, Genetic<br/>Proto-Oncogene Proteins B-raf--genetics<br/>Receptors, Thyrotropin--genetics<br/>Thyroid Neoplasms--genetics